← The Wire
FATENasdaq
FATE THERAPEUTICS INC
Biological Products, (No Diagnostic Substances) · CIK 1434316
Develops off-the-shelf cellular immunotherapies from engineered stem cells for broad patient access
red 8-K · 90d
$240M
Market cap
$2.42
Last close
+15.2%
1D
+12.6%
5D
5.9M
Volume
Price · last 39 sessions+34.4%
May 4L $1.73 · H $2.84Jun 29
249
Total filings
Jun 15, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 15, 20268-KCompany UpdateJun 4, 202610-Q10-QMay 13, 20268-KResults of OperationsMay 13, 2026DEFA14ADEFA14AApr 24, 2026DEF 14ADEF 14AApr 24, 2026SC 13D/ASC 13D/AApr 22, 202610-K10-KFeb 26, 20268-KResults of OperationsFeb 26, 202610-Q10-QNov 13, 20258-KResults of OperationsNov 13, 20258-KReg FD Disclosure · Company UpdateOct 27, 20258-KExecutive Change · Reg FD DisclosureOct 14, 202510-Q10-QAug 12, 20258-KResults of Operations · Exit / Disposal CostsAug 12, 20258-K/AShareholder VoteJun 17, 20258-KExecutive Change · Bylaw AmendmentMay 30, 202510-Q10-QMay 13, 20258-KResults of OperationsMay 13, 2025DEFA14ADEFA14AApr 17, 2025DEF 14ADEF 14AApr 17, 202510-K10-KMar 5, 20258-KResults of OperationsMar 5, 20258-KExecutive ChangeJan 6, 20258-KExecutive Change · Reg FD DisclosureNov 29, 202410-Q10-QNov 12, 20248-KResults of OperationsNov 12, 20248-KExecutive Change · Material AgreementAug 30, 202410-Q10-QAug 13, 20248-KResults of OperationsAug 13, 20248-KExecutive Change · Reg FD DisclosureJul 31, 20248-KBylaw AmendmentJun 10, 20248-KExecutive Change · Shareholder VoteJun 7, 20248-KExecutive ChangeMay 31, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 20248-KReg FD Disclosure · Company UpdateMay 9, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 20248-KMaterial Agreement · Equity IssuanceMar 21, 2024424B5424B5Mar 20, 202410-K10-KFeb 26, 20248-KResults of OperationsFeb 26, 2024SC 13GSC 13GFeb 12, 2024SC 13GFATE THERAPEUTICS INCJan 25, 20248-KMaterial Agreement · Agreement TerminatedNov 8, 202310-Q10-QNov 8, 20238-KResults of OperationsNov 8, 20238-KCompany UpdateSep 1, 202310-Q10-QAug 8, 20238-KResults of OperationsAug 8, 20238-KShareholder VoteJun 9, 20238-KExecutive ChangeJun 8, 20238-KCompany UpdateJun 7, 202310-Q10-QMay 3, 20238-KResults of OperationsMay 3, 2023DEFA14ADEFA14AApr 21, 2023DEF 14ADEF 14AApr 21, 20238-KDelisting Notice · Bylaw AmendmentApr 19, 2023SC 13GSC 13GMar 22, 202310-K10-KFeb 28, 20238-KResults of OperationsFeb 28, 2023SC 13GSEC SCHEDULE 13GFeb 13, 2023SC 13GSC 13GFeb 3, 20238-KExecutive Change · Agreement TerminatedJan 5, 20238-KMaterial Agreement · Reg FD DisclosureNov 7, 202210-Q10-QNov 3, 20228-KResults of OperationsNov 3, 202210-Q10-QAug 3, 20228-KResults of OperationsAug 3, 20228-KMaterial Agreement · Reg FD DisclosureJun 30, 20228-KExecutive Change · Shareholder VoteJun 13, 202210-Q10-QMay 4, 20228-KResults of OperationsMay 4, 2022DEFA14ADEFA14AApr 25, 2022DEF 14ADEF 14AApr 25, 202210-K10-KFeb 28, 20228-KResults of OperationsFeb 28, 20228-KCompany UpdateDec 14, 20218-KMaterial Agreement · Agreement TerminatedNov 4, 2021
Insider Activity
In the 90 days to Jan 9, 2026: 2 sold $17K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 9, 2026 | Tahl CindySee Remarks | Sell | 10,589 | $1.06 | $11K |
| Jan 9, 2026 | Valamehr BahramPresident and CEO | Sell | 5,190 | $1.07 | $6K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance